CARL ZEISS MEDITEC ADR 1 (AFXA) — Cash Flow Reinvestment Rate
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €144.16 Million. Explore AFXA capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CARL ZEISS MEDITEC ADR 1 Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Also explore AFXA current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year capital reinvestment analysis for CARL ZEISS MEDITEC ADR 1. For live market cap and broader valuation context, see CARL ZEISS MEDITEC ADR 1 (AFXA) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | €102.25 Million | €209.86 Million | €76.59 Million | ▼ -86.6% |
| 2024 | 3.63x | €898.32 Million | €247.32 Million | €152.20 Million | ▲ +617.2% |
| 2023 | 0.51x | €127.05 Million | €250.86 Million | €113.86 Million | ▼ -27.9% |
| 2022 | 0.70x | €132.13 Million | €188.20 Million | €81.97 Million | — |